ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

EU-Canada Patents Row

The dispute between Canada and the European Union on patent protection of pharmaceutical products in which India was associated as a third party, is of considerable significance. It recognises the import of India's arguments which lay stress on the basic principle of national treatment embodied in the various intellectual property right conventions.



Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top